ROTHSCHILD INVESTMENT LLC /IL - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 29 filers reported holding CANCER GENETICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROTHSCHILD INVESTMENT LLC /IL ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q2 2014$136,000
-24.9%
12,0000.0%0.02%
-29.2%
Q1 2014$181,000
-57.9%
12,000
-61.5%
0.02%
-59.3%
Q4 2013$430,00031,2000.06%
Other shareholders
CANCER GENETICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 836,908$3,431,0003.54%
Fairbanks Capital Management, Inc. 233,170$956,0000.94%
DIKER MANAGEMENT LLC 63,315$260,0000.12%
EAM Investors, LLC 117,878$483,0000.08%
WEDBUSH SECURITIES INC 87,000$357,0000.05%
Acrospire Investment Management LLC 11,090$45,0000.04%
TWO SIGMA SECURITIES, LLC 16,053$66,0000.01%
THOMPSON DAVIS & CO., INC. 2,000$8,0000.01%
Manchester Capital Management LLC 9,000$37,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 40,158$165,0000.00%
View complete list of CANCER GENETICS INC shareholders